Clinical Report: Link Between Estimated Glucose Disposal Rate and Mortality in Breast Cancer Survivors

Overview

This study investigates the association between estimated glucose disposal rate (eGDR) and overall as well as breast cancer-specific mortality among breast cancer survivors in the U.S. The findings suggest that lower eGDR is linked to higher mortality risks, highlighting the importance of metabolic health in cancer survivorship.

Background

Breast cancer is a leading cause of cancer-related deaths among women, necessitating the exploration of factors that influence survival outcomes. Insulin resistance (IR) is increasingly recognized as a significant factor affecting breast cancer prognosis. The estimated glucose disposal rate (eGDR) serves as a non-invasive measure of IR, making it a valuable tool for assessing metabolic health in breast cancer survivors.

Data Highlights

Key Findings

• Lower eGDR levels correlate with increased insulin resistance in breast cancer survivors.
• eGDR is a reliable surrogate for assessing metabolic health in large epidemiological studies.
• Higher eGDR is independently associated with lower all-cause mortality in breast cancer survivors.
• eGDR may serve as a potential target for metabolic interventions to improve survival outcomes.
• Insulin resistance is linked to breast cancer progression and poorer prognosis.

Clinical Implications

Healthcare providers should consider monitoring eGDR as part of survivorship care for breast cancer patients. Addressing insulin resistance through lifestyle modifications and metabolic interventions may improve long-term outcomes for these patients.

Conclusion

The study underscores the critical role of metabolic health, as indicated by eGDR, in influencing mortality among breast cancer survivors. Further research is warranted to explore targeted interventions that could enhance survival rates.

References

1. Association of estimated glucose disposal rate with all-cause and breast cancer-specific mortality in US breast cancer survivors: a population-based study, BMC Cancer, 2025 -- Title
2. American Journal of Epidemiology — Utilizing a Registry-Based Method to Assess Racial Disparities in Breast Cancer Mortality at the County Level: A Study in Georgia
3. The Journal of Clinical Endocrinology & Metabolism — Assessment of Diabetes Mellitus Prevalence and Influencing Factors in 2338 Long-Term Survivors of Childhood Cancer in the Netherlands (DCCS-LATER2 Study)
4. The Journal of Clinical Endocrinology & Metabolism — Associations of Glycemic Measures in the Normal Range With All-Cause Mortality in the Absence of Traditional Risk Factors
5. NCCN Guidelines® Insights - Survivorship, Version 2.2025 | NCCN Continuing Education
6. The Journal of Clinical Endocrinology & Metabolism — Relationship Between Serum Albumin-to-Globulin Ratio and Mortality Outcomes in Diabetic Patients
7. NCCN Guidelines® Insights - Survivorship, Version 2.2025 | NCCN Continuing Education
8. Association of estimated glucose disposal rate with all-cause and breast cancer-specific mortality in US breast cancer survivors: a population-based study | BMC Cancer | Springer Nature Link
9. Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial - PMC